Women's Tabloid

Viemed to acquire Lehan’s Medical Equipment for $26M, expanding into women’s health

Viemed Healthcare, Inc. announces its acquisition of Lehan’s Medical Equipment as part of its broader strategy to diversify its offerings and expand into new healthcare sectors, particularly women’s health.

Follow Us:

Picture of Women's Tabloid News Desk
Women's Tabloid News Desk

Viemed Healthcare, Inc. has announced that it is set to acquire Illinois-based Lehan’s Medical Equipment in a deal valued at $26 million. This acquisition is part of Viemed’s broader strategy to diversify its offerings and expand into new healthcare sectors, particularly women’s health.

The move was confirmed on 6 May 2025 via a statement from the company, which trades on the NASDAQ under the ticker VMD. Viemed specialises in post-acute respiratory care, offering equipment and in-home clinical services across the United States.

Viemed Chief Executive Officer Casey Hoyt. said, “Operating for nearly 80 years, Lehan has established a well-deserved reputation for its expertise in home medical equipment with a particular emphasis on women’s health and a deep commitment to community engagement. Lehan gives us a strong platform to execute our growth strategy in a large and fast-growing market with very familiar products. The acquisition also diversifies our product mix into maternal health that we expect to extend to our existing payer relationships across the country. This is a highly motivated and experienced team that has created tremendous brand equity, and we are pleased to join forces with them.”

Lehan’s Medical Equipment is a family-owned business established in 1946 and based in DeKalb, Illinois. They specialise in women’s health products such as breast pumps, as well as respiratory care. The firm operates three full-service branches in Northern Illinois and an additional three sleep and CPAP setup locations in the West Chicagoland area, including one site in Wisconsin.

Lehan generated around $25.7 million in net revenue and approximately $7.4 million in Adjusted EBITDA in 2024. The purchase includes an estimated $2.2 million in contingent payments and is subject to standard working capital adjustments.

The deal is expected to close in Q3 of 2025, with Viemed funding the transaction through existing cash reserves and credit facilities.

Owners Jim and Jon Lehan, along with their team of over 90 employees, will remain with the business following the acquisition.

Share:

Digital Edition

Top Picks